Evidence map›Paper›PMID 26034175›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

CD11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent APCs.

Anatoly V Rubtsov, Kira Rubtsova, John W Kappler, Jordan Jacobelli, Rachel S Friedman, Philippa Marrack

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 234 citations in OpenAlex.

  1. The Antigen Presenting Potential of CD21Frontiers in immunology · 2020
    Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Human CD21Journal of human immunity · 2026
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Anatoly V RubtsovHoward Hughes Medical Institute, Department of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206; rubtsova@njhealth.org marrackp@njhealth.org.
Kira RubtsovaDepartment of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206;
John W KapplerHoward Hughes Medical Institute, Department of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206; Department of Pharmacology, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045; and.
Jordan JacobelliDepartment of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206;
Rachel S FriedmanDepartment of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206;
Philippa MarrackHoward Hughes Medical Institute, Department of Biomedical Research, National Jewish Health, Denver, CO 80206; Department of Immunology and Microbiology, University of Colorado Denver, Anschutz Medical Campus, Denver, CO 80206; Department of Medicine, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045; and Department of Biochemistry and Molecular Genetics, University of Colorado Denver, Anschutz Medical Campus, Aurora, CO 80045 rubtsova@njhealth.org marrackp@njhealth.org.
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USNational Jewish Health · US

Funding

THE REGULATION OF V ALPHA 7 EXPRESSING T CELLSP01AI022295 · NIAID · NATIONAL JEWISH HEALTH · PI REFAELI, YOSEF · 1985 to 2011
$11.7M
MHC peptide tetramers in type 1 diabetesU19AI046374 · NIAID · UNIVERSITY OF COLORADO DENVER · PI HOLERS, VERNON MICHAEL · 1999 to 2007
$9.6M
CHARACTERISTICS OF T CELL RECEPTORSR01AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1985 to 2022
$7.3M
Molecular Mechanisms of Immune ToleranceT32AI074491 · NIAID · NATIONAL JEWISH HEALTH · PI CAMBIER, JOHN C, PELANDA, ROBERTA · 2009 to 2023
$4.1M
CHARACTERISTICS OF T-CELL RECEPTORSR37AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 1992 to 2001
$522k
Characteristics of T Cell ReceptorsR56AI018785 · NIAID · NATIONAL JEWISH HEALTH · PI MARRACK, PHILIPPA C. · 2012 to 2012
$410k
Howard Hughes Medical InstituteNIAID NIH HHS AI-046374NIAID NIH HHS AI-18785NIAID NIH HHS AI-22295NIAID NIH HHS P01 AI022295NIAID NIH HHS R01 AI018785NIAID NIH HHS R37 AI018785NIAID NIH HHS R56 AI018785NIAID NIH HHS T32 AI-074491NIAID NIH HHS T32 AI074491NIAID NIH HHS U19 AI046374
6 · The paper itself

Abstract

In addition to the secretion of Ag-specific Abs, B cells may play an important role in the generation of immune responses by efficiently presenting Ag to T cells. We and other investigators recently described a subpopulation of CD11c(+) B cells (Age/autoimmune-associated B cells [ABCs]) that appear with age, during virus infections, and at the onset of some autoimmune diseases and participate in autoimmune responses by secreting autoantibodies. In this study, we assessed the ability of these cells to present Ag and activate Ag-specific T cells. We demonstrated that ABCs present Ag to T cells, in vitro and in vivo, better than do follicular B cells (FO cells). Our data indicate that ABCs express higher levels of the chemokine receptor CCR7, have higher responsiveness to CCL21 and CCL19 than do FO cells, and are localized at the T/B cell border in spleen. Using multiphoton microscopy, we show that, in vivo, CD11c(+) B cells form significantly more stable interactions with T cells than do FO cells. Together, these data identify a previously undescribed role for ABCs as potent APCs and suggest another potential mechanism by which these cells can influence immune responses and/or the development of autoimmunity.

Indexed as

AutoimmunityAgingAnimalsAntigen-Presenting CellsAutoantibodiesB-LymphocytesCD11c AntigenChemokine CCL19Chemokine CCL21FemaleGene Expression RegulationMiceMice, Inbred C57BLReceptors, CCR7Signal TransductionSpleenAutoantibodiesCcl19 protein, mouseCcr7 protein, mouseCD11c AntigenChemokine CCL19Chemokine CCL21Receptors, CCR7

Identifiers

PMID26034175
PMCPMC4475418
OpenAlexW1798290921

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.